IL10 and atherosclerosis: FLI1 regulates the expression of metalloproteases (MMP-1, MMP-3, and MMP-10) and the pro-inflammatory cytokine IL-10; therefore, during chronic inflammatory conditions, such as AR and atherosclerosis, FLI1 down-regulation could attenuate tissue damage associated with inflammatory responses [76].